Medicine and Dentistry
Breast Cancer
100%
Recurrent Disease
51%
Cohort Analysis
50%
Tamoxifen
41%
Malignant Neoplasm
33%
Metastatic Breast Cancer
28%
Estrogen Receptor
18%
Premenopause
17%
Patient Compliance
16%
Hormone Therapy
16%
Tissue Microarray
16%
Image Analysis
16%
Cohort Effect
16%
Standardized Incidence Ratio
16%
Cancer Prognosis
16%
Diabetes Mellitus
16%
Patient Registry
16%
Non Small Cell Lung Cancer
16%
Adjuvant Endocrine Therapy
16%
Hazard Ratio
16%
Multidrug Resistance Associated Protein 2
16%
Single Nucleotide Polymorphism
16%
Case-Control Study
16%
Odds Ratio
15%
Cumulative Incidence
14%
Medical Record
12%
B-Cell Chronic Lymphocytic Leukemia
11%
Drug Therapy
11%
Docetaxel
9%
Primary Tumor
8%
Disease
8%
Colorectal Cancer
7%
Population
7%
Pharmacokinetics
6%
CYP3A
6%
Cancer Mortality
6%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Recurrent Disease
48%
Tamoxifen
41%
Cohort Study
34%
Chemotherapy
29%
Metastatic Breast Cancer
20%
Estrogen Receptor
18%
Multidrug Resistance-Associated Protein 2
16%
Taxane
16%
Congenital Malformation
16%
Patient Registry
16%
Non Small Cell Lung Cancer
16%
Case-Control Study
16%
Overall Survival
16%
Endocrine Therapy
16%
Event Free Survival
12%
Malignant Neoplasm
11%
Docetaxel
9%
Disease
8%
Primary Tumor
8%
Comorbidity
8%
Pharmacokinetics
6%
CYP3A
6%
SLCO1B1
6%
Cancer Mortality
6%
